Viewing nowYuhan Metformin Hydrochloride Tablet 850 mg
Metformin Hydrochloride 850mg
Tablet · Prescription medication
Yuhan Corporation

MFDS item code 202000351 · Approved 2020.01.21 · Insurance code 642105560
Treatment of type 2 diabetes mellitus
This medication is used for the treatment of Type 2 diabetes. It is particularly helpful in cases where blood sugar control is difficult with diet and exercise alone. It can also be used as an alternative treatment when sulfonylureas are ineffective or cause side effects. This medication helps effectively control blood sugar levels and aids in managing diabetes.
The dose should be determined individually based on drug response and tolerability, and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control, this medicine must be started at a low dose: 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When doses up to 2000mg are used, the dose is usually divided into 2 doses per day, taken in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 doses per day and take with meals; the maximum daily dose is 2550mg. At initiation of treatment and when adjusting the dose, measure fasting blood glucose to assess response to this medicine and identify the minimum effective dose. Measure blood glycated hemoglobin levels approximately every 3 months. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose blood glucose was previously controlled by diet alone, short-term use of this medicine may be sufficient to achieve an adequate effect. Patients with renal impairment This medicine may be used, with the following dose adjustments, in patients with moderate (moderate) renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this medicine must be discontinued immediately.
Children aged 10 years and older or adolescents who are growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. The maximum daily dose is 2000mg, divided into 2~3 doses.
This medication can cause severe lactic acidosis or hypoglycemia, so caution is necessary. It should not be administered to patients with moderate to severe renal impairment or those with acute infections, dehydration, or acute cardiac conditions. Patients with acute heart failure or unstable heart failure, or those scheduled for examinations involving iodine-based contrast media should also avoid this medication. Patients with a history of allergic reactions to this medication or similar drugs, Type 1 diabetes, and those with a history of lactic acidosis or ketoacidosis are not suitable candidates for this treatment. Patients with severe infections or traumatic injuries should temporarily discontinue this medication until gastrointestinal function recovers and renal function returns to normal. If surgery is planned, especially surgeries with restricted food or fluid intake, this medication should be stopped 48 hours before the procedure and can be resumed after ensuring that renal function is normal post-surgery. Patients with very poor nutritional status, starvation, severe weakness, liver dysfunction, severe lung disease, or excessive alcohol consumption should also use caution when taking this medication. During pregnancy, it is advisable not to use this medication if there is a risk of placental insufficiency, gestational hypertension, or intrauterine growth restriction. Patients with irregular meals, intense physical exercise, or potential interactions with other medications should use this medication cautiously due to the risk of hypoglycemia or lactic acidosis. Gastrointestinal side effects (diarrhea, nausea, vomiting, etc.) may occur during treatment, and if symptoms are severe or persistent, consulting with a healthcare professional is necessary. Lactic acidosis, though rare, is a very serious side effect; if symptoms such as muscle pain, weakness, difficulty breathing, abdominal pain, or changes in consciousness occur, stop taking the medication immediately and inform a healthcare professional. Renal function tests should be conducted before and regularly during treatment with this medication to monitor for any decline in renal function, and treatment should be stopped if renal function deteriorates significantly. Alcohol consumption can increase the risk of side effects from this medication, so excessive drinking should be avoided during treatment. Vitamin B12 deficiency may occur, thus regular checks of serum vitamin B12 levels are recommended. When used in combination with other hypoglycemic agents, the risk of hypoglycemia may increase; therefore, caution is needed, particularly for elderly patients or those with nutritional imbalances. During pregnancy, careful monitoring of the fetal and maternal condition is essential, and insulin therapy may be considered if necessary. If breastfeeding, since this medication can be excreted in breast milk, careful consideration of breastfeeding status and medication treatment is required. Elderly patients often have decreased renal function, so dose adjustment and monitoring of renal function are essential. In cases of overdose, hypoglycemia is rare, but there is a risk of lactic acidosis; appropriate treatment such as hemodialysis should be administered if necessary. This medication is also available for children and adolescents, but their growth and development should be closely monitored.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air and moisture and should be kept at room temperature between 1°C and 30°C. This will help maintain the effectiveness of the medication for a longer time.
White oblong film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 850mg
Tablet · Prescription medication
Yuhan Corporation

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.